LEANNE GRONEMEYER: Open Payments
NPI 1659521045 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$756 in 36 payments from 16 companies in 2025. Trend: 2023 $467 · 2024 $551 · 2025 $756
Food & beverage: $756
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $128 |
| Indivior Inc. | 5 | $83 |
| Astellas Pharma US Inc | 3 | $76 |
| ABBVIE INC. | 3 | $73 |
| Lilly USA, LLC | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Aimmune Therapeutics, Inc. | 2 | $39 |
| Almatica Pharma LLC | 1 | $27 |
| Hologic Sales and Service, LLC | 1 | $26 |
Products named: SUBLOCADE, Veozah, MOUNJARO, CAPLYTA, Wegovy, Ozempic, Rybelsus, ZENPEP.
Industry payments across CO — which companies pay providers there.
